Published in Clin Exp Dermatol on January 01, 2005
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production. J Cosmet Dermatol (2003) 3.33
Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology (2000) 3.01
Glutathione-S-transferase family of enzymes. Mutat Res (2001) 2.74
Alternate splicing produces a novel cyclin D1 transcript. Oncogene (1995) 2.48
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol (1998) 2.37
Basal cell carcinoma. BMJ (2003) 2.10
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
Initial metabolic and hormonal response to acute myocardial infarction. Lancet (1974) 2.02
The human glutathione S-transferases: studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes. Ann Hum Genet (1984) 1.85
Identification of two lithocholic acid-binding proteins. Separation of ligandin from glutathione S-transferase B. Biochem J (1979) 1.71
Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am J Respir Crit Care Med (2000) 1.61
The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ (1999) 1.60
Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett (2000) 1.59
Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res (1995) 1.56
Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol (2002) 1.54
Epigenetic control of fetal gene expression. BJOG (2007) 1.51
The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer (1997) 1.49
Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet (2001) 1.42
Standard effective doses for proliferative tumours. Phys Med Biol (1999) 1.39
The development of glutathione S-transferase and glutathione peroxidase activities in human lung. Biochim Biophys Acta (1986) 1.30
Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology (2000) 1.30
GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis. Gut (1993) 1.30
A study of the structures of the YaYa and YaYc glutathione S-transferases from rat liver cytosol. Evidence that the Ya monomer is responsible for lithocholate-binding activity. Biochem J (1981) 1.29
Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis (1996) 1.28
Metabolic polymorphisms and cancer susceptibility. Cancer Surv (1995) 1.26
Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res (1995) 1.25
Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics (1998) 1.25
Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis (2000) 1.24
Cholic acid binding by glutathione S-transferases from rat liver cytosol. Biochem J (1980) 1.24
The human glutathione S-transferases: developmental aspects of the GST1, GST2, and GST3 loci. Biochem Genet (1985) 1.23
Equilibrium-dialysis studies of the interaction between cholic acid and 100000g-supernatant preparations from the rat liver. Biochem J (1976) 1.22
Basal cell carcinoma. J R Soc Med (1998) 1.20
Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet (1994) 1.20
Polymorphisms at the glutathione S-transferase, GSTP1 locus: a novel mechanism for susceptibility and development of atopic airway inflammation. Allergy (2000) 1.19
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res (2000) 1.18
Susceptibility to basal cell carcinoma: associations with PTCH polymorphisms. Ann Hum Genet (2004) 1.17
Partial purification of two lithocholic acid-binding proteins from rat liver 100 000g supernatants. Biochem J (1977) 1.16
Binding of bile acids by 100 000g supernatants from rat liver. Biochem J (1977) 1.16
Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J (1999) 1.15
Studies of the development of basic, neutral and acidic isoenzymes of glutathione S-transferase in human liver, adrenal, kidney and spleen. Biochem J (1987) 1.14
Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1/CIP1) expression and correlates with patient survival. Int J Cancer (2001) 1.13
Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice. BMJ (2001) 1.09
Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. Biochem J (1993) 1.08
The human glutathione S-transferases. Immunohistochemical studies of the developmental expression of Alpha- and Pi-class isoenzymes in liver. Biochem J (1988) 1.07
Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res (1996) 1.06
Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med (1997) 1.06
Effects of glutathione S-transferase M1, T1 and P1 on lung function in asthmatic families. Clin Exp Allergy (2005) 1.06
Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis (1999) 1.06
Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual. Carcinogenesis (1996) 1.03
Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J (1995) 1.02
Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitope. Ann Rheum Dis (1999) 1.01
Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc (2001) 1.00
Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population. Brain (2004) 1.00
The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. Carcinogenesis (1993) 1.00
The human glutathione S-transferases: comparison of isoenzyme expression in normal and astrocytoma brain. Biochim Biophys Acta (1992) 1.00
The glyceryl [14C]tripalmitate breath test: a reassessment. Clin Chim Acta (1980) 1.00
The sources of plasma cyclic AMP: studies in the rat using isoprenaline, nicotinic acid and glucagon. Eur J Clin Invest (1975) 1.00
Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuroimmunol (2002) 1.00
Multiple basal cell carcinomas and malignant melanoma following radiotherapy for ankylosing spondylitis. Clin Exp Dermatol (2000) 0.99
Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol (2003) 0.99
Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem Biol Interact (1998) 0.98
Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol (2001) 0.98
Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res (1998) 0.97
S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. Br J Cancer (2004) 0.97
Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br J Dermatol (2000) 0.96
Genetics and risk factors for basal cell carcinoma. Br J Dermatol (2006) 0.95
Studies on the variability of glutathione S-transferase from human erythrocytes. Clin Chim Acta (1982) 0.95
Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology (2004) 0.95
A comparison of erythrocyte glutathione S-transferase activity from human foetuses and adults. Biochem J (1980) 0.95
Glutathione S-transferase in human brain. Neuropathol Appl Neurobiol (1990) 0.94
Simultaneous identification of GSTP1 Ile105-->Val105 and Ala114-->Val114 substitutions using an amplification refractory mutation system polymerase chain reaction assay: studies in patients with asthma. Respir Res (2001) 0.94